Access will open to ESMO Members on 11 Aug.
fc-falcon">Abstracts; Congress Officers.
May 9, 2023 · ESMO Breast Cancer Congress 2023 Abstract Title: EMERALD trial analysis of patient-reported outcomes (PROs) in patients with ER+/HER2− advanced or metastatic breast cancer (mBC) comparing oral. .
ESMO Breast Cancer 2023 took place as a hybrid meeting, onsite in Berlin, Germany, on 11-13 May 2023, and online, through a virtual platform.
Travel Grant application deadline 06 March 2023.
Payment deadline is 6 September 2023. . .
Markets back off as debt deadline looms 17 hours ago @ the Bell: TSX moves lower as.
. May 25, 2023 · Presentation Date and Time: Thursday, June 29, 2023, at 8:50 – 9:00 AM CEST. (2023-05-25 | NDAQ:RNXT) RenovoRx Announces Late-Breaking Oral Presentation at 2023 ESMO World Congress on Gastrointestinal Cancer (2023-05-25 | NDAQ:.
fc-falcon">Abstracts; Congress Officers. .
Early registration deadline: 6 September 2023 at 23:59 CET.
.
Abstracts and ePosters are open access. 00.
. May 9, 2023 · ESMO Breast Cancer Congress 2023 Abstract Title: EMERALD trial analysis of patient-reported outcomes (PROs) in patients with ER+/HER2− advanced or metastatic breast cancer (mBC) comparing oral.
Presenting Author: Michael Jon Pishvaian,.
May 31, 2023.
. . asco.
The deadline to upload the participant names and details is 4 October 2023. Abstract Withdrawal Deadline: April 9, 2023, at 11:59 PM (ET) Abstract Titles, including. The deadline to upload the participant names and details is 4 October 2023. . May 2, 2019 · fc-falcon">Resources from ESMO Breast Cancer 2023 are available according to the presenters' agreement to release them. .
.
Access will open to ESMO Members on 11 Aug. .
ESMO Breast Cancer is a congress designed for breast cancer researchers and clinicians who have a specific interest in innovation (including translational research, new agents, molecular and functional diagnostics, biomarkers and cutting-edge research.
fc-falcon">Abstracts; Congress Officers.
.
.
#ESMO23: Register by 19 July to get the early rate ⏰ Submitted abstracts show an impressive growth of over 30% compared to 2022 so prepare to take part in a meeting.